Fisher & Paykel Healthcare Corporation Limited (FPH.AX)

24,33 -0,04 (-0,16%) A partir del 01:46PM AEST. Mercado abierto.

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
https://www.fphcare.com

Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 6391

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Lewis G. Gradon	MD, CEO & Executive Director	2,35M	N/A	1961
Ms. Lyndal York	Chief Financial Officer	N/A	N/A	N/A
Andy Niccol	COO & GM of Respiratory Humidification	N/A	N/A	N/A
Dr. Andrew Somervell	Vice President of Products & Technology	N/A	N/A	N/A
Hayden Brown	Head of Capital Markets & Investor Relations	N/A	N/A	N/A
Raelene Leonard	Company Secretary & General Counsel	N/A	N/A	N/A
Daniel Adolph	Senior Communications & Investor Relations Manager	N/A	N/A	N/A
Mr. Justin Callahan	VP of Sales & Marketing and President of North America & Europe	N/A	N/A	N/A
Ms. Nicola Talbot	Vice President of Human Resources	N/A	N/A	N/A
Mr. Jonathan Rhodes	Vice President of Supply Chain, Facilities & Sustainability	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en AUD.

Descripción

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Gobierno corporativo

El ISS Governance QualityScore de Fisher & Paykel Healthcare Corporation Limited, a día 1 de abril de 2024, es 6. Las puntuaciones base son Auditoría: 5; Tablero: 5; Derechos de los accionistas: 7; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.